{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:20:34Z","timestamp":1784604034288,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2021,1,19]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Expensive cancer treatment calls for alternative ways such as drug repurposing to develop effective drugs. The aim of this study was to analyse the effect of post-diagnostic use of cholera vaccine on survival outcome in breast cancer patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cancer diagnosis and cholera vaccination were obtained by linkage of several Swedish national registries. One vaccinated patient was matched with maximum two unvaccinated individuals based on demographic, clinical and socioeconomic factors. We performed proportional Cox regression model to analyse the differences in overall and disease-specific survivals between the matched patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 617 patients received cholera vaccine after breast cancer diagnosis. The median (interquartile range) time from diagnosis to vaccination was 30 (15\u201351) months and from vaccination to the end of follow-up it was 62 (47\u201385) months. Among them, 603 patients were matched with 1194 unvaccinated patients. Vaccinated patients showed favourable overall survival (hazard ratio (HR): 0.54, 95% confidence interval (CI): 0.37\u20130.79) and disease-specific survival (HR: 0.53, 95% CI: 0.33\u20130.84), compared to their unvaccinated counterpart. The results were still significant in multiple sensitivity analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Post-diagnostic use of cholera vaccine is associated with a favourable survival rate in breast cancer patients; this provides evidence for repurposing it against breast cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41416-020-01108-9","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T01:03:24Z","timestamp":1602032604000},"page":"506-512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association of post-diagnostic use of cholera vaccine with survival outcome in breast cancer patients"],"prefix":"10.1038","volume":"124","author":[{"given":"Guoqiao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"1108_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"1108_CR2","doi-asserted-by":"publisher","unstructured":"Aggarwal, S., Verma, S. S., Aggarwal, S. & Gupta, S. C. Drug repurposing for breast cancer therapy: old weapon for new battle. Semin. Cancer Biol. https:\/\/doi.org\/10.1016\/j.semcancer.2019.09.012 (2019).","DOI":"10.1016\/j.semcancer.2019.09.012"},{"key":"1108_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","volume":"34","author":"SD Ramsey","year":"2016","unstructured":"Ramsey, S. D., Bansal, A., Fedorenko, C. R., Blough, D. K., Overstreet, K. A., Shankaran, V. et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J. Clin. Oncol. 34, 980 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1108_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A. et al. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1108_CR5","doi-asserted-by":"crossref","unstructured":"Dastjerdi, M. N., Salahshoor, M. R., Mardani, M., Hashemibeni, B. & Roshankhah, S. The effect of CTB on P53 protein acetylation and consequence apoptosis on MCF-7 and MRC-5 cell lines. Adv. Biomed. Res. 2, 24 (2013).","DOI":"10.4103\/2277-9175.108005"},{"key":"1108_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1348-0421.2005.tb03632.x","volume":"49","author":"I Isomura","year":"2005","unstructured":"Isomura, I., Yasuda, Y., Tsujimura, K., Takahashi, T., Tochikubo, K. & Morita, A. Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity. Microbiol. Immunol. 49, 79\u201387 (2005).","journal-title":"Microbiol. Immunol."},{"key":"1108_CR7","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1002\/eji.200324135","volume":"33","author":"YI Kawamura","year":"2003","unstructured":"Kawamura, Y. I., Kawashima, R., Shirai, Y., Kato, R., Hamabata, T., Yamamoto, M. et al. Cholera toxin activates dendritic cells through dependence on GM1\u2010ganglioside which is mediated by NF\u2010\u03baB translocation. Eur. J. Immunol. 33, 3205\u20133212 (2003).","journal-title":"Eur. J. Immunol."},{"key":"1108_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1189\/jlb.1103534","volume":"75","author":"EC Lavelle","year":"2004","unstructured":"Lavelle, E. C., Jarnicki, A., McNeela, E., Armstrong, M. E., Higgins, S. C., Leavy, O. et al. Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent. J. Leukoc. Biol. 75, 756\u2013763 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"1108_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-3083.2009.02321.x","volume":"71","author":"JB Sun","year":"2010","unstructured":"Sun, J. B., Czerkinsky, C. & Holmgren, J. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand. J. Immunol. 71, 1\u201311 (2010).","journal-title":"Scand. J. Immunol."},{"key":"1108_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/carcin\/bgu325","volume":"36","author":"M Doulberis","year":"2014","unstructured":"Doulberis, M., Angelopoulou, K., Kaldrymidou, E., Tsingotjidou, A., Abas, Z., Erdman, S. E. et al. Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer. Carcinogenesis 36, 280\u2013290 (2014).","journal-title":"Carcinogenesis"},{"key":"1108_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04814-4","volume":"9","author":"J Ji","year":"2018","unstructured":"Ji, J., Sundquist, J. & Sundquist, K. Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients. Nat. Commun. 9, 2367 (2018).","journal-title":"Nat. Commun."},{"key":"1108_CR12","doi-asserted-by":"publisher","first-page":"86.e1","DOI":"10.1053\/j.gastro.2017.09.009","volume":"154","author":"J Ji","year":"2018","unstructured":"Ji, J., Sundquist, J. & Sundquist, K. Cholera vaccine use is associated with a reduced risk of death in patients with colorectal cancer: a population-based study. Gastroenterology 154, 86.e1\u201392.e1 (2018).","journal-title":"Gastroenterology"},{"key":"1108_CR13","unstructured":"Edge, S. B., Byrd, D. R., Carducci, M. A., Compton, C. C., Fritz, A. & Greene, F. AJCC Cancer Staging Manual (Springer, New York, 2010)."},{"key":"1108_CR14","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","volume":"28","author":"MD Holmes","year":"2010","unstructured":"Holmes, M. D., Chen, W. Y., Li, L., Hertzmark, E., Spiegelman, D. & Hankinson, S. E. Aspirin intake and survival after breast cancer. J. Clin. Oncol. 28, 1467 (2010).","journal-title":"J. Clin. Oncol."},{"key":"1108_CR15","doi-asserted-by":"crossref","unstructured":"Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C. et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care 43, 1130\u20131139 (2005).","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"1108_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine, J. P. & Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94, 496\u2013509 (1999).","journal-title":"J. Am. Stat. Assoc."},{"key":"1108_CR17","unstructured":"Lindqvist, L. & Lindkvist, P. R\u00e5d och profylax vid resa. https:\/\/lakemedelsboken.se\/kapitel\/antibiotika_och_reseprofylax\/rad_och_profylax_vid_resa.html#l2_61 (2018)."},{"key":"1108_CR18","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrclinonc.2015.169","volume":"12","author":"F Bertolini","year":"2015","unstructured":"Bertolini, F., Sukhatme, V. P. & Bouche, G. Drug repurposing in oncology\u2014patient and health systems opportunities. Nat. Rev. Clin. Oncol. 12, 732 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1108_CR19","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3892\/mmr.2014.2054","volume":"9","author":"X Zheng","year":"2014","unstructured":"Zheng, X., Ou, Y., Shu, M., Wang, Y., Zhou, Y., Su, X. et al. Cholera toxin, a typical protein kinase A activator, induces G1 phase growth arrest in human bladder transitional cell carcinoma cells via inhibiting the c\u2011Raf\/MEK\/ERK signaling pathway. Mol. Med. Rep. 9, 1773\u20131779 (2014).","journal-title":"Mol. Med. Rep."},{"key":"1108_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1440-1711.1999.00840.x","volume":"77","author":"X Han","year":"1999","unstructured":"Han, X., Papadopoulos, A. J., Jones, T., Devaja, O. & Raju, K. S. Cholera toxin\u2010induced alteration of the phenotype and behaviour of an ovarian carcinoma cell line, SR8. Immunol. Cell Biol. 77, 377\u2013384 (1999).","journal-title":"Immunol. Cell Biol."},{"key":"1108_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/bjc.1993.53","volume":"67","author":"E Ohmura","year":"1993","unstructured":"Ohmura, E., Wakai, K., Isozaki, O., Murakami, H., Onoda, N., Emoto, N. et al. Inhibition of human pancreatic cancer cell (MIA PaCa-2) growth by cholera toxin and 8-chloro-cAMP in vitro. Br. J. Cancer 67, 279 (1993).","journal-title":"Br. J. Cancer"},{"key":"1108_CR22","doi-asserted-by":"publisher","first-page":"13438","DOI":"10.1073\/pnas.0701990104","volume":"104","author":"Y Li","year":"2007","unstructured":"Li, Y., Yin, W., Wang, X., Zhu, W., Huang, Y. & Yan, G. Cholera toxin induces malignant glioma cell differentiation via the PKA\/CREB pathway. Proc. Natl Acad. Sci. USA 104, 13438\u201313443 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1108_CR23","first-page":"1473","volume":"43","author":"YS Cho-Chung","year":"1983","unstructured":"Cho-Chung, Y. S., Clair, T., Shepheard, C. & Berghoffer, B. Arrest of hormone-dependent mammary cancer growth in vivo and in vitro by cholera toxin. Cancer Res. 43, 1473\u20131476 (1983).","journal-title":"Cancer Res."},{"key":"1108_CR24","first-page":"153","volume":"133","author":"J S\u00e1nchez","year":"2011","unstructured":"S\u00e1nchez, J. & Holmgren, J. Cholera toxin\u2014a foe & a friend. Indian J. Med. Res. 133, 153 (2011).","journal-title":"Indian J. Med. Res."},{"key":"1108_CR25","doi-asserted-by":"publisher","first-page":"9387","DOI":"10.18632\/oncotarget.3328","volume":"6","author":"JR Lakritz","year":"2015","unstructured":"Lakritz, J. R., Poutahidis, T., Mirabal, S., Varian, B. J., Levkovich, T., Ibrahim, Y. M. et al. Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget 6, 9387 (2015).","journal-title":"Oncotarget"},{"key":"1108_CR26","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1073\/pnas.1904022116","volume":"117","author":"JH Newman","year":"2020","unstructured":"Newman, J. H., Chesson, C. B., Herzog, N. L., Bommareddy, P. K., Aspromonte, S. M., Pepe, R. et al. Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer. Proc. Natl Acad. Sci. USA 117, 1119\u20131128 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1108_CR27","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.3390\/ijerph16132375","volume":"16","author":"S Oftedal","year":"2019","unstructured":"Oftedal, S., Vandelanotte, C. & Duncan, M. J. Patterns of diet, physical activity, sitting and sleep are associated with socio-demographic, behavioural, and health-risk indicators in adults. Int. J. Environ. Res. Public Health 16, 2375 (2019).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"1108_CR28","doi-asserted-by":"crossref","unstructured":"Fredj, S. B., Ghammem, R., Maatoug, J., Zammit, N., Hasni, Y., Chelly, S. et al. Association between physical inactivity and socioeconomic factors and lifestyle among Tunisian adolescents. Endocr. Abstr. 63, P977 (2019).","DOI":"10.1530\/endoabs.63.P977"},{"key":"1108_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/afepuc-2017-0011","volume":"57","author":"D Novak","year":"2017","unstructured":"Novak, D., Lovro, \u0160., Antala, B., Emeljanovas, A., Mieziene, B., Milanovi\u0107, I. et al. The associations between socioeconomic status and lifestyle factors in European adolescents: a population-based study. Acta Facultatis Educationis Phys. Universitatis Comen. 57, 111\u2013124 (2017).","journal-title":"Acta Facultatis Educationis Phys. Universitatis Comen."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01108-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01108-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01108-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T01:19:27Z","timestamp":1633569567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01108-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,19]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1038\/s41416-020-01108-9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"6 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As this study was based on anonymous information from the Swedish national registries and study participants were never contacted, it was approved by the Ethics Committee of Lund University without requirement for informed consent. Through advertisements in the major newspapers, people could chose to opt out before the research database were constructed. The study was performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The use of these data is governed by an agreement with the Swedish National Board of Health and Welfare with J.S., which does not allow redistribution of original data. Anyone who is interested in the data set should contact the Swedish National Board of Health and Welfare and apply for the access to the data set (). If anyone gets the approval, they can get access to the database in the same manner as the authors. The project database is located at Center for Primary Health Care in Malm\u00f6, Sweden.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}